OZ Management LP Buys New Stake in Envision Healthcare Co. (EVHC)

OZ Management LP bought a new position in shares of Envision Healthcare Co. (NYSE:EVHC) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund bought 2,936,289 shares of the company’s stock, valued at approximately $131,987,000. OZ Management LP owned 2.43% of Envision Healthcare at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. ING Groep NV lifted its stake in Envision Healthcare by 0.3% in the 2nd quarter. ING Groep NV now owns 6,022 shares of the company’s stock valued at $377,000 after acquiring an additional 21 shares in the last quarter. CIBC Asset Management Inc lifted its stake in Envision Healthcare by 0.4% in the 2nd quarter. CIBC Asset Management Inc now owns 10,078 shares of the company’s stock valued at $632,000 after acquiring an additional 38 shares in the last quarter. Sawtooth Solutions LLC lifted its stake in Envision Healthcare by 0.7% in the 2nd quarter. Sawtooth Solutions LLC now owns 6,656 shares of the company’s stock valued at $417,000 after acquiring an additional 43 shares in the last quarter. Boys Arnold & Co. Inc. lifted its stake in Envision Healthcare by 0.6% in the 2nd quarter. Boys Arnold & Co. Inc. now owns 8,125 shares of the company’s stock valued at $509,000 after acquiring an additional 50 shares in the last quarter. Finally, PNC Financial Services Group Inc. lifted its stake in Envision Healthcare by 1.5% in the 2nd quarter. PNC Financial Services Group Inc. now owns 4,848 shares of the company’s stock valued at $304,000 after acquiring an additional 70 shares in the last quarter.

Shares of Envision Healthcare Co. (NYSE EVHC) traded up $0.09 during midday trading on Tuesday, reaching $30.83. The company’s stock had a trading volume of 3,414,500 shares, compared to its average volume of 2,235,818. The company has a current ratio of 3.01, a quick ratio of 3.00 and a debt-to-equity ratio of 0.89. Envision Healthcare Co. has a 52-week low of $23.77 and a 52-week high of $74.75. The firm has a market cap of $3,716.14, a price-to-earnings ratio of 9.49, a price-to-earnings-growth ratio of 0.80 and a beta of 0.57.

Envision Healthcare (NYSE:EVHC) last issued its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.08). Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. The firm had revenue of $1.99 billion during the quarter, compared to analyst estimates of $2.03 billion. During the same period in the prior year, the company earned $1.13 earnings per share. The business’s quarterly revenue was up 142.0% compared to the same quarter last year. research analysts expect that Envision Healthcare Co. will post 2.57 EPS for the current year.

Envision Healthcare declared that its Board of Directors has approved a share repurchase plan on Monday, September 18th that permits the company to repurchase $250.00 million in outstanding shares. This repurchase authorization permits the company to purchase up to 4.5% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board of directors believes its stock is undervalued.

Several equities research analysts have commented on EVHC shares. Jefferies Group set a $71.00 target price on Envision Healthcare and gave the company a “buy” rating in a research note on Wednesday, November 1st. KeyCorp set a $67.00 target price on Envision Healthcare and gave the company a “buy” rating in a research note on Wednesday, November 1st. Cantor Fitzgerald cut Envision Healthcare from an “overweight” rating to a “neutral” rating and set a $30.00 price objective on the stock. in a research note on Wednesday, November 1st. Canaccord Genuity reiterated a “buy” rating and set a $32.00 price objective (down previously from $68.00) on shares of Envision Healthcare in a research note on Thursday, November 2nd. Finally, Bank of America dropped their price objective on Envision Healthcare from $72.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, October 9th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $47.57.

COPYRIGHT VIOLATION WARNING: “OZ Management LP Buys New Stake in Envision Healthcare Co. (EVHC)” was posted by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.com-unik.info/2017/12/05/oz-management-lp-buys-new-stake-in-envision-healthcare-co-evhc.html.

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Institutional Ownership by Quarter for Envision Healthcare (NYSE:EVHC)

What are top analysts saying about Envision Healthcare Co.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Envision Healthcare Co. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit